This instrument is the Health Insurance (Section 3C Pathology Services – COVID-19) Amendment (No. 4) Determination 2020.

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. The whole of this instrument	Immediately after registration of this instrument.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority

This instrument is made under subsection 3C(1) of the Health Insurance Act 1973.

4 Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1— Amendments

Health Insurance (Section 3C Pathology Services – COVID-19) Determination 2020

1 Section 5 (below the definition of bulk‑billed)

Insert:

aged care service has the same meaning as defined by the Aged Care
Act 1997.

approved provider has the meaning as given by the Aged Care
Act 1997.

2 Section 5 (before clinically relevant service in the Note)

Insert:

accredited pathology laboratory;

3 Section 6 (below the heading)

Repeal and substitute:

(1) For a service to which items 69476, 69477, 69479 or 69480 applies, a relevant service, provided in accordance with this instrument and as a clinically relevant service, is to be treated, for the relevant provisions, as if:

(a) it were both a professional service and a pathology service; and

(b) there were an item in the pathology services table that:

(i) related to the service; and

(ii) specified for the service a fee in relation to each State, being the fee specified in the Schedule in relation to the service.

(2) For a service to which item 69501 applies, a relevant service, provided in accordance with this instrument and as a clinically relevant service, is to be treated, for the relevant provisions, as if:

(a) it were a pathology service, other than provisions of the Act relating to pathology requests; and

(b) there were an item in the pathology services table that:

(iii) related to the service; and

(iv) specified for the service a fee in relation to each State, being the fee specified in the Schedule in relation to the service.

(3) For the purpose of paragraph 6(2)(a), provisions of the Act relating to pathology requests include (but are not limited to) section 16A (other than subsections 16A(2), (5AB), (6) to (10).

4 Schedule 1 (after item 69480)

Insert:

69501

Detection of a SARS‑CoV‑2 nucleic acid 1 or more tests if:

(a) the person is employed, hired, retained or contracted by an approved provider, or works in an aged care service, in Victoria; and

(b) the person is informed of the results of the tests within 24 hours of receipt of the specimen at an accredited pathology laboratory; and

(c) the results of the test are reported to all appropriate authorities in accordance with Victorian legislation or regulations within 24 hours of receipt of the specimen at an accredited pathology laboratory; and

(d) the person is not a private patient in a recognised hospital; and

(e) the person is not an admitted patient of a hospital; and

(f) the service is not performed in a prescribed laboratory as described in 4.1 of the pathology services table

Other than a service to which an item in this instrument or an item in the pathology services tables applies.

Where the service is bulk‑billed.

110.00